Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia

NCT05213104 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Patent Foramen Ovale
Atrial Arrhythmia
Cryptogenic Stroke

Interventions

DRUG: Flecainide
DRUG: Flecainide

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]